196302-52-0

Upstream product

• 196302-51-9 (3-Bromo-2,5-dimethoxy-phenyl)-methanol 

Downstream Products

• 551001-76-4 5-hydroxy-2-(4-hydroxy-phenyl)-7-methoxy-benzofuran-4-carbaldehyde oxime 
• 782486-33-3 2-(3-fluoro-4-hydroxy-phenyl)-7-methoxy-benzofuran-5-ol 
• 551001-22-0 5-Hydroxy-2-(4-hydroxy-phenyl)-7-methoxy-benzofuran-4-carbaldehyde 
• 782486-32-2 7-bromo-2-(3-fluoro-4-hydroxy-phenyl)-benzofuran-5-ol 
• 551001-66-2 2-(3-Bromo-2,5-dimethoxy-phenyl)-1-(4-methoxy-phenyl)-ethanone 
• 551001-68-4 7-bromo-2-(4-hydroxy-phenyl)-benzofuran-5-ol 
• 551001-19-5 2-(4-Hydroxy-phenyl)-7-methoxy-benzofuran-5-ol 
• 782486-30-0 (3-bromo-2,5-dimethoxy-phenyl)-acetyl chloride 
• 551001-65-1 (3-bromo-2,5-dimethoxy-phenyl)-acetic acid 

Relevant academic research and scientific papers

PHARMACEUTICAL COMPOSITIONS AND METHODS OF PREVENTING, TREATING, OR INHIBITING INFLAMMATORY DISEASES, DISORDERS, OR CONDITIONS OF THE SKIN, AND DISEASES, DISORDERS, OR CONDITIONS ASSOCIATED WITH COLLAGEN DEPLETION

The present invention provides compositions and methods for preventing, treating, or inhibiting inflammatory diseases, disorders, or conditions of the skin, and diseases, disorders, or conditions associated with collagen depletion using one or more estrogenic agents.

Tetracyclic compounds as estrogen ligands

This invention provides estrogen receptor modulators having the structure: wherein R1, R2, R3, R4, Q, n, R8, R9, R10, and R11 have been defined in the specification; o

7-Substituted 2-phenyl-benzofurans as ERβ selective ligands

Substituted benzofuran 21 is a potent and selective ER ligand. A series of 2-(4-hydroxy-phenyl)-benzofuran-5-ols with relatively lipophilic groups in the 7-position of the benzofuran was prepared and the affinity and selectivity for ERβ was measured. Many

Substituted 2-phenyl benzofurans as estrogenic agents

This invention provides estrogen receptor modulators of formula I, having the structure wherein R, R′, A, A′, X, Y, and Y are as defined in the specification, or a pharmaceutically acceptable salt thereof.

AMINOTETRALIN DERIVATIVES AND COMPOSITIONS AND METHOD OF USE THEREOF

The invention relates to aminotetralin derivatives of the formula I: wherein: R1 is methyl or ethyl; R2 is hydrogen, halogen, lower-alkoxy or thiolower-alkyl; R3 is hydrogen, halogen, lower-alkoxy or lower-alkyl; and the chiral center * is in the

Aminotetralin derivative and compositions and method of use thereof

The invention relates to aminotetralin derivatives of the formula I: STR1 wherein: R1 is methyl or ethyl; R2 is hydrogen, halogen, lower-alkoxy or thiolower-alkyl; R3 is hydrogen, halogen, lower-alkoxy or lower-alkyl; and